Home › Funds › Alpine Peaks Capital, LP › TECH

Alpine Peaks Capital, LP position in TECH

BIO-TECHNE CORP · Health Care

Alpine Peaks Capital, LP reported holding 66,960 shares of TECH (BIO-TECHNE CORP) in its Q2 2026 13F filing — a position valued at US$4.7M, representing 5.54% of its reported portfolio and ranking #9 among its reported holdings. Alpine Peaks Capital, LP has disclosed TECH holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)66.96K sh
Reported value held$4.73M
Portfolio Weight5.54%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Alpine Peaks Capital, LP's TECH position evolved

Alpine Peaks Capital, LP first disclosed a stake in TECH in Q1 2025 at 10,000 shares (US$586K). The position peaked in Q2 2026 at 66,960 shares, worth US$4.7M. Across 6 filings, Alpine Peaks Capital, LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 66,960 shares valued at US$4.7M — a reduction of -7,040 shares quarter over quarter.. Notable position changes include a 120% increase in Q2 2025 (shares rose 8% over the following quarter), a 64% increase in Q3 2025 (shares rose 6% over the following quarter), a 44% increase in Q1 2026 (shares rose 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 10.00K $586.30K New
Q2 2025 22.00K $1.13M Add
Q3 2025 36.00K $2.00M Add
Q4 2025 51.50K $3.03M Add
Q1 2026 74.00K $3.87M Add
Q2 2026 66.96K $4.73M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (BIO-TECHNE CORP) is a Health Care company. 29 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has Alpine Peaks Capital, LP held TECH?

Alpine Peaks Capital, LP has disclosed TECH holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Alpine Peaks Capital, LP's current position in TECH?

As of Q2 2026, Alpine Peaks Capital, LP holds 66.96K shares of TECH (BIO-TECHNE CORP), valued at $4.73M, representing 5.54% of its reported portfolio and ranking #9.

Has Alpine Peaks Capital, LP been buying or selling TECH?

In the latest 13F filing (Q2 2026), Alpine Peaks Capital, LP reduced its position in TECH. The position peaked in Q2 2026 at 66.96K shares.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.